U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Papillary cystadenocarcinoma

MedGen UID:
64635
•Concept ID:
C0206700
•
Neoplastic Process
Synonyms: Cystadenocarcinoma, Papillary; Cystadenocarcinomas, Papillary; Papillary Cystadenocarcinoma; Papillary Cystadenocarcinomas
SNOMED CT: Papillary cystadenocarcinoma (2735009); Papillocystic adenocarcinoma (2735009)
 
Monarch Initiative: MONDO:0005074

Definition

A malignant cystic serous or mucinous epithelial neoplasm characterized by the presence of malignant glandular epithelial cells forming papillary structures. Stromal invasion is present. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPapillary cystadenocarcinoma

Professional guidelines

PubMed

Diagnosis and Management of Pancreatic Cystic Neoplasms.
Kim TS, Fernandez-del Castillo C
Hematol Oncol Clin North Am 2015 Aug;29(4):655-74. Epub 2015 Jun 6 doi: 10.1016/j.hoc.2015.04.002. PMID: 26226903
Mucins in the diagnosis and differential diagnosis of pancreatic cystic neoplasms: report of 40 cases.
Ji Y, Tan YS, Xu JF, Qi WD, Li XP, Su-Jie AS, Zhu XZ
Chin Med J (Engl) 2006 May 5;119(9):765-8. PMID: 16718948
The changing prognosis and treatment in cancer of the ovary. A report of 235 patients with primary ovarian carcinoma 1952-1961.
Munnell EW
Am J Obstet Gynecol 1968 Mar 15;100(6):790-805. doi: 10.1016/s0002-9378(15)33580-8. PMID: 4296050

Recent clinical studies

Etiology

Low-grade serous ovarian cancer: expert consensus report on the state of the science.
Grisham RN, Slomovitz BM, Andrews N, Banerjee S, Brown J, Carey MS, Chui H, Coleman RL, Fader AN, Gaillard S, Gourley C, Sood AK, Monk BJ, Moore KN, Ray-Coquard I, Shih IM, Westin SN, Wong KK, Gershenson DM
Int J Gynecol Cancer 2023 Sep 4;33(9):1331-1344. doi: 10.1136/ijgc-2023-004610. PMID: 37591609Free PMC Article
Uterine papillary serous carcinoma: state of the state.
Naumann RW
Curr Oncol Rep 2008 Nov;10(6):505-11. doi: 10.1007/s11912-008-0076-x. PMID: 18928665
FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival.
Memarzadeh S, Holschneider CH, Bristow RE, Jones NL, Fu YS, Karlan BY, Berek JS, Farias-Eisner R
Int J Gynecol Cancer 2002 Sep-Oct;12(5):454-8. doi: 10.1046/j.1525-1438.2002.01149.x. PMID: 12366662
Adjuvant chemotherapy for high-risk endometrial cancer.
Pustilnik T, Burke TW
Semin Radiat Oncol 2000 Jan;10(1):23-8. doi: 10.1016/s1053-4296(00)80017-x. PMID: 10671655
Well-differentiated serous neoplasms of the ovary.
Longacre TA, Kempson RL, Hendrickson MR
Pathology (Phila) 1993;1(2):255-306. PMID: 9420921

Diagnosis

Low-grade serous ovarian cancer: expert consensus report on the state of the science.
Grisham RN, Slomovitz BM, Andrews N, Banerjee S, Brown J, Carey MS, Chui H, Coleman RL, Fader AN, Gaillard S, Gourley C, Sood AK, Monk BJ, Moore KN, Ray-Coquard I, Shih IM, Westin SN, Wong KK, Gershenson DM
Int J Gynecol Cancer 2023 Sep 4;33(9):1331-1344. doi: 10.1136/ijgc-2023-004610. PMID: 37591609Free PMC Article
Novel therapeutics in low-grade serous ovarian cancer.
Cobb L, Gershenson D
Int J Gynecol Cancer 2023 Mar 6;33(3):377-384. doi: 10.1136/ijgc-2022-003677. PMID: 36878564
Central cystadenocarcinoma of the mandible.
Takei R, Tomihara K, Arai N, Noguchi M
Int J Oral Maxillofac Surg 2012 Dec;41(12):1463-6. Epub 2012 May 8 doi: 10.1016/j.ijom.2012.04.006. PMID: 22571862
Woody hands.
Alexandroff AB, Hazleman BL, Matthewson M, Black CM, Rytina E, Crawford R, Burrows NP
Lancet 2003 Apr 19;361(9366):1344. doi: 10.1016/s0140-6736(03)13082-6. PMID: 12711470
Well-differentiated serous neoplasms of the ovary.
Longacre TA, Kempson RL, Hendrickson MR
Pathology (Phila) 1993;1(2):255-306. PMID: 9420921

Therapy

Low-grade serous ovarian cancer: expert consensus report on the state of the science.
Grisham RN, Slomovitz BM, Andrews N, Banerjee S, Brown J, Carey MS, Chui H, Coleman RL, Fader AN, Gaillard S, Gourley C, Sood AK, Monk BJ, Moore KN, Ray-Coquard I, Shih IM, Westin SN, Wong KK, Gershenson DM
Int J Gynecol Cancer 2023 Sep 4;33(9):1331-1344. doi: 10.1136/ijgc-2023-004610. PMID: 37591609Free PMC Article
Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review.
Yuan J, He L, Han B, Li Y
World J Surg Oncol 2017 Apr 11;15(1):76. doi: 10.1186/s12957-017-1134-3. PMID: 28399919Free PMC Article
Malignant degeneration of perineal endometriosis in episiotomy scar, case report and review of the literature.
Chene G, Darcha C, Dechelotte P, Mage G, Canis M
Int J Gynecol Cancer 2007 May-Jun;17(3):709-14. Epub 2007 Feb 9 doi: 10.1111/j.1525-1438.2007.00822.x. PMID: 17300680
Primary papillary serous cystadenocarcinoma of broad ligament.
Nagar YS, Singh S, Sawlani V, Pal L, Dimri K, Lal P
Australas Radiol 2005 Apr;49(2):160-2. doi: 10.1111/j.1440-1673.2005.01365.x. PMID: 15845057
Adjuvant chemotherapy for high-risk endometrial cancer.
Pustilnik T, Burke TW
Semin Radiat Oncol 2000 Jan;10(1):23-8. doi: 10.1016/s1053-4296(00)80017-x. PMID: 10671655

Prognosis

Syringocystadenocarcinoma papilliferum with locoregional metastases.
Satter E, Grady D, Schlocker CT
Dermatol Online J 2014 Apr 16;20(4):22335. PMID: 24746298
Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature.
Demirci S, Yavas F, Ozsaran Z, Ozsaran A, Dikmen Y, Zekioglu O, Karabulut B, Aras AB
Med Oncol 2010 Sep;27(3):628-31. Epub 2009 Jun 18 doi: 10.1007/s12032-009-9259-z. PMID: 19536657
Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology.
Dietel M, Hauptmann S
Virchows Arch 2000 May;436(5):403-12. doi: 10.1007/s004280050467. PMID: 10881733
Adjuvant chemotherapy for high-risk endometrial cancer.
Pustilnik T, Burke TW
Semin Radiat Oncol 2000 Jan;10(1):23-8. doi: 10.1016/s1053-4296(00)80017-x. PMID: 10671655
Well-differentiated serous neoplasms of the ovary.
Longacre TA, Kempson RL, Hendrickson MR
Pathology (Phila) 1993;1(2):255-306. PMID: 9420921

Clinical prediction guides

Syringocystadenocarcinoma Papilliferum In Situ, a Variant of Cutaneous Adenocarcinoma In Situ: A Case Report With Literature Review.
Chen J, Beg M, Chen S
Am J Dermatopathol 2016 Oct;38(10):762-5. doi: 10.1097/DAD.0000000000000687. PMID: 27533073
Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact?
Goodman MT, Shvetsov YB
Int J Cancer 2009 May 1;124(9):2231-5. doi: 10.1002/ijc.24184. PMID: 19127596Free PMC Article
Diverse tumorigenic pathways in ovarian serous carcinoma.
Singer G, Kurman RJ, Chang HW, Cho SK, Shih IeM
Am J Pathol 2002 Apr;160(4):1223-8. doi: 10.1016/s0002-9440(10)62549-7. PMID: 11943707Free PMC Article
Adjuvant chemotherapy for high-risk endometrial cancer.
Pustilnik T, Burke TW
Semin Radiat Oncol 2000 Jan;10(1):23-8. doi: 10.1016/s1053-4296(00)80017-x. PMID: 10671655
Observations on the etiology and pathogenesis of intraductal papillary-mucinous neoplasms of the pancreas.
Longnecker DS
Hepatogastroenterology 1998 Nov-Dec;45(24):1973-80. PMID: 9951850

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Reviews

    Related information

    • MeSH
      Related Medical Subject Headings
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...